跳至主要内容
临床试验/TCTR20180815004
TCTR20180815004尚未招募未知

10% Lidocaine spray for pain control during intrauterine device insertion in nulliparous women: A randomized, double-blinded, placebo controlled Trial

Faculty of Medicine Siriraj Hospital0 个研究点目标入组 124 人开始时间: 2018年5月15日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
124

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 45 Years(—)
性别
Female

入选标准

  • Woman who required for Copper T IUD insertion
  • Age 18-45 years
  • New IUD user
  • Body mass index 18.5 †30 kg/m2
  • Communicable with Thai language

排除标准

  • Suspicion of pregnancy
  • Puerperal sepsis/Immediate post-septic abortion
  • Untreated abnormal uterine bleeding
  • Uterine anomaly/abnormal pathology distorting the uterine cavity
  • Current pelvic inflammatory disease
  • Untreated cervicitis/vaginitis
  • Wilson’s disease
  • Copper allergy
  • known hypersensitivity to local anaesthetics.
  • Analgesic or anxiolytic use within the last 24 h before the procedure

研究者

相似试验